A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum β-lactamases

  • Vicki M. Ensor*
  • , D. M. Livermore
  • , P. M. Hawkey
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)

    Abstract

    Objectives: To develop a reverse-line hybridization assay to identify CTX-M genotypes, potentially useful for large-scale investigation of surveillance collections. Methods: Isolates carrying previously characterized blaCTX-M genes were used to develop the method. In addition, 334 isolates from five separate surveys were used to validate the method. CTX-M group was known from an independent multiplex PCR for 122 isolates and genotype was confirmed for 80 isolates by DNA sequencing. A multiplex PCR was designed to amplify a genotype-specific region within the blaCTX-M open-reading frame. Oligonucleotides were designed to hybridize to regions within each amplicon, covering mutations that distinguish among blaCTX-M genotypes. Results: CTX-M phylogenetic groups were identified by the multiplex PCR with 100% concordance. The reverse-line hybridization assay specifically identified commonly-reported variants within these groups (98.7% concordance). Conclusions: The hybridization method enabled precise identification of CTX-M genes, rather than just to group level, without the need for DNA sequencing. In its present format, the method enables 43 isolates to be processed per membrane, giving results within one working day. It is a useful tool for the epidemiological investigation of blaCTX-M genes among survey collections of Enterobacteriaceae.

    Original languageEnglish
    Pages (from-to)387-395
    Number of pages9
    JournalJournal of Antimicrobial Chemotherapy
    Volume59
    Issue number3
    DOIs
    Publication statusPublished - Mar 2007

    Bibliographical note

    Funding Information:
    We are grateful to L. Tzouvelakis, R. Bonnet, S. Kariuki, P. Nordmann and G. Bou and their teams for very kindly providing control isolates used in the development and validation of this work. We thank M. Warner, R. Warren, K. Nye, P. Kumari, J. Mandozana and V. Rotimi for providing some of the isolates used in the validation of this assay. This work was presented in part at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005. This work was financially supported by the British Society for Antimicrobial Chemotherapy, grant number GA550. We acknowledge receipt of BBSRC grant 6/JIF13209 awarded to the Functional Genomics Laboratory, University of Birmingham, UK, which supports DNA sequencing work, and are grateful to J. Moore for secretarial support.

    Copyright:
    Copyright 2009 Elsevier B.V., All rights reserved.

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • ESBLs
    • Genotyping
    • Molecular epidemiology
    • Multiplex PCR

    Fingerprint

    Dive into the research topics of 'A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum β-lactamases'. Together they form a unique fingerprint.

    Cite this